Elsallab, Magdi

Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

Abou-el-Enein, M., Elsallab, M., Feldman, S. A., Fesnak, A. D., Heslop, H. E., Marks, P., Till, B. G., Bauer, G., & Savoldo, B. (2021) · Blood Cancer Discovery

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 321

CAR T cell product performance in haematological malignancies before and after marketing authorisation

Elsallab, M., Levine, B. L., Wayne, A. S., & Abou-El-Enein, M. (2020) · The Lancet Oncology

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 81

Mitigating deficiencies in evidence during regulatory assessments of advanced therapies: a comparative study with other biologicals

Elsallab, M., Bravery, C. A., Kurtz, A., & Abou-El-Enein, M. (2020) · Molecular Therapy - Methods & Clinical Development

Biomedical Ethics and RegulationPharmaceutical Economics and Policy

Cited by 59